Trial intelligence / Profile preview

Bioequivalence study of entacapone 200 mg film-coated tablet under fasting conditions in healthy volunteers

TCTR20200107002Completed

Sponsor
Unison Laboratories
Start
Feb 2020
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of entacapone (2 arms), sponsored by Unison Laboratories. Primary endpoints: Cmax, AUC0-t and 2 more. Started Feb 2020; status: completed.

02

Drugs

entacapone

Beyond the preview

Go deeper on TCTR20200107002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20200107002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call